B. Riley Securities Initiates Coverage On Praxis Precision Medicine with Buy Rating, Announces Price Target of $713

Benzinga · 1d ago
B. Riley Securities analyst Madison El-Saadi initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Price Target of $713.